Ginkgo Bioworks Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNA research report →
About the company
Ginkgo Bioworks Holdings, Inc. , alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products.
- CEO
- Jason Kelly
- IPO
- 2021
- Employees
- 834
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $679.37M
- P/E
- -1.94
- P/S
- 4.81
- P/B
- 1.40
- EV/EBITDA
- -4.49
- Div Yield
- 0.00%
- Gross Margin
- 74.97%
- Op Margin
- -210.66%
- Net Margin
- -215.41%
- ROE
- -57.31%
- ROIC
- -31.12%
- Revenue
- $170.16M · -25.06%
- Net Income
- $-312,763,000 · 42.83%
- EPS
- $-5.64 · 46.49%
- Op Income
- $-315,278,000
- FCF YoY
- 53.23%
- 52W High
- $17.58
- 52W Low
- $5.37
- 50D MA
- $8.75
- 200D MA
- $9.33
- Beta
- 1.78
- Avg Volume
- 1.26M
Get TickerSpark's AI analysis on DNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | HENRY CHRISTIAN O | other | 25,000 |
| Jun 11, 26 | Fubini Ross | other | 25,000 |
| Jun 11, 26 | Kosuri Sri | other | 25,000 |
| Jun 11, 26 | SLOAN HARRY | other | 25,000 |
| May 21, 26 | Coen Steven P. | other | 156 |
| May 21, 26 | Coen Steven P. | other | 587 |
| May 22, 26 | Coen Steven P. | sell | 307 |
| May 21, 26 | Coen Steven P. | other | 587 |
| May 21, 26 | Coen Steven P. | other | 156 |
| Apr 16, 26 | Coen Steven P. | other | 156 |
Our DNA coverage
Recent articles, reports, and earnings notes.
No research on DNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNA report →Similar companies
Peers in the same neighborhood.